910449-74-0

Upstream product

• 910449-73-9 2-(3,9-Bis(carboxymethyl)-3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1⁽¹⁴⁾,11⁽¹⁵⁾,12-trien-6-yl)-4-(4-nitrophenyl)butyric acid 
• 353246-05-6 tert-butyl 3,9-bis(2-nitrophenylsulfonyl)-3,6,9,15-tetraazabicyclo[9.3.1]pentadecane-1⁽¹⁵⁾,11,13-triene-6-carbamate 
• 910449-70-6 3,9-bis(ethoxycarbonylmethyl)-3,6,9,15-tetraaza-bicyclo[9.3.1]pentadeca-1⁽¹⁴⁾,11⁽¹⁵⁾,12-triene-6-carboxylic acid, tert-butyl ester of 
• 910449-71-7 (9-ethoxycarbonylmethyl-3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1⁽¹⁵⁾,11,13-trien-3-yl)acetic acid, ethyl ester of 
• 910449-72-8 2-(3,9-bis(ethoxycarbonylmethyl)-3,6,9,15-tetraazabicyclo-[9.3.1]pentadeca-1⁽¹⁴⁾,11⁽¹⁵⁾,12-trien-6-yl)-4-(4-nitrophenyl)butyric acid, methyl ester of 

Downstream Products

• 910449-48-8 4-(4-aminophenyl)-2-(3,9-bis(carboxymethyl)-3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1⁽¹⁴⁾,11⁽¹⁵⁾,12-trien-6-yl)butyric acid, gadolinium complex of 

Relevant academic research and scientific papers

Lipophilic chelates and their use in imaging

The invention relates to chelate compounds which can be used in MRI, the chelates being intended to be conveyed by lipophilic transporters, such as lipid nanoparticles or liposomes. The invention also relates to compounds comprising, in association, these chelates and these transporters, if appropriate connected via chemical bonding groups, and to their use in diagnostic imaging, it being possible for this association additionally to comprise biological targeting markers, denoted biovectors.